PATENT CLAIM ANALYSIS

Application Number: 16329139
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-07
Patent Classification: ["514", "019300"]

Abstract:
The present invention relates to a peptide having anticancer activity, and a pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer including the same as an active ingredient, and more particularly, to a peptide set forth in SEQ ID NO: 1, wherein the peptide binds to a transcription factor CP2 c  and has prophylactic and therapeutic activities against cancer, and a pharmaceutical composition, a health functional food composition and a functional cosmetic composition for preventing and treating cancer including the same as an active ingredient. <SEQ ID NO: 1> Tyr-Pro-Gln-Arg

Claim (Index 2):
The peptide of  claim 1 , wherein acetyl and amide groups are bound to N-terminal Tyr and C-terminal Arg of the peptide set forth in SEQ ID NO: 1, respectively.

Metadata:
- Claim Count in Document: 36.0
- Percentile: 99.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15563533', '13547601', '14736735', '11972487', '13015456']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8057189928443255
- 35 USC 102 Novelty (BERT): 0.5810662223331649
- Combined Prediction Score: 0.7832537157932095
- Mean Citation Score: 368.422426
- Max Citation Score: 492.79413
- Similarity Product: 414.85770178546426

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test